NCT06335264Completed
A Multimodal Wearable Platform for Heart Failure Disease Stratification
Screening for Heart Failure Using a Multimodal Wearable Device
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to find out if there are any patterns in the way people's bodies react to physical activities and their voices when they have heart failure, a disease where the heart cannot function sufficiently. To do this, the investigators will use a smartwatch that can measure multiple signals like the participant's heart rate and movement. Investigators will ask participants with and without heart failure to wear the Watch HOP (from HOP-Child Technologies Inc.) and sensors during physical tasks at their clinic visit at the McGill University Health Centre. Researchers will also record the participants' voices between their visits. The key signals can help find who is at risk for heart failure or develop new ways to monitor and treat it.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 56 (actual)
- First submitted
- 13 Mar 2024
- Start date
- 15 Jan 2024
- Primary completion date
- 29 Jul 2025
- Lead sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Diseases
- Heart failure
- NCT number
- NCT06335264
What you commit to
- Study type: Observational
- Participants enrolled: 56
- From 15 Jan 2024 to the primary completion date, 29 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Undergoing chemotherapy or dialysis
Other
- Any person who does not meet the above criteria or who refuses to participate
- In addition, the following list of criteria are specific to accurate wrist wearable measurements:
- Skin burns or rashes on the measurement locations (wrist for wearable, finger for oximeter, chest for Polar ECG)
- Patients with tremors
- Recent use of dermatological creams, ointments, or lotions at the recording area
Who the study is looking for
- Able to follow up with the study protocol schedule
- Life expectancy \> 1 year
- Case group only
- Clinical signs and/or symptoms of heart failure caused by a structural and/or functional cardiac abnormality, as defined by Bozkurt et al. \[2021\], diagnosed at the cardiovascular clinic
- NT-proBNP levels \> 125 pg/L or objective evidence of cardiogenic pulmonary or systemic congestion
- One of the following;
- For HFpEF, LVEF ≥ 50% ii. For HFmrEF, LVEF 41-49% iii. For HFrEF, LVEF ≤ 40%
- Control group only
- Absence of known clinical heart failure history.
- Absence of criteria above in the case group.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| McGill University Health Centre Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.